The success of Sildenafil initially drove a period of growth for pharma, nevertheless recent developments present a complicated picture for those considering a stake. Generic competitors are eating into revenue, and https://murrayqmut144753.mybloglicious.com/61092429/sildenafil-and-big-pharma-a-risky-investment